HIPRA

Hipra Laboratories, S.A. is a Spanish multinational pharmaceutical and biotechnology corporation initially focused on veterinary medicine, later moving into human vaccines to manage COVID-19.[1] The PHH-1V vaccine entered clinical trials in Spain in August 2021.


References
  1. Limón, Raúl (2021-08-12). "First Spanish Covid-19 vaccine approved for human clinical trial". EL PAÍS English Edition. Retrieved 2021-11-05.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.